CompletedPHASE1, PHASE2NCT01548729
Metabolic Efficiency of Combined Pancreatic Islet and Lung Transplant for the Treatment of End-Stage Cystic Fibrosis
Studying Cystic fibrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Strasbourg, France
- Principal Investigator
- Laurence KESSLER, MD, PhDHôpitaux Universitaires de Strasbourg
- Intervention
- Combined pancreatic islet and lung transplantation(procedure)
- Enrollment
- 14 enrolled
- Eligibility
- 14 years · All sexes
- Timeline
- 2012 – 2019
Study locations (28)
- CRCM AdulteCHU de Grenoble, Hôpital A. Michallon, Grenoble, France
- Nephrologie, CHU Grenoble, Grenoble, France
- Réanimation Cardiovasculaire et Thoracique, Hôpital Michallon, Grenoble, France
- Service d'Endocrinologie, CHU de Grenoble, Grenoble, France
- Service de Chirurgie Cardiaque, CHU Grenoble, Grenoble, France
- Service de Radiologie Interventionnelle, CHU de Grenoble, Grenoble, France
- Service de Pneumologie, Hôpital A. MICHALLON , CHU de Grenoble, Grenoble, France
- Service d'Urologie et chirurgie de la Transplantation, Groupement Hospitalier Edouard Herriot, Lyon, France
- Service de médecine de la transplantation et immunologie clinique, Hôpital Edouard Herriot, Lyon, France
- CRCM adulte, Centre Hospitalier Lyon-Sud, Lyon, France
- Service d'Endocrinologie, Pavillon médical, Lyon, France
- Service d'imagerie radiologique et de médecine nucléaire, Centre Hospitalier Lyon-Sud, Lyon, France
- Service de Chirurgie Thoracique, HOPITAL LOUIS PRADEL, Lyon, France
- Service de pneumologie, Hôpital Louis Pradel, Lyon, France
- Service de la Clinique d'Endocrinologie, maladies métaboliques et Nutrition, Nantes, France
- +13 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01548729 on ClinicalTrials.govOther trials for Cystic fibrosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07437105Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy ParticipantsVertex Pharmaceuticals Incorporated
- RECRUITINGNANCT07436351ACT With CF Self-Help ToolkitThomas Jefferson University
- RECRUITINGNANCT07314229Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-IvacaftorUniversity Hospital, Lille
- RECRUITINGNCT07083557Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)Bettina Mittendorfer
- RECRUITINGNCT07369414Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households: A Case-control Study of Exposure Risk at HomeResearch Center Borstel
- RECRUITINGNCT07505797ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)iSono Health, Inc.
- RECRUITINGPHASE1NCT07283770Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy ParticipantsVertex Pharmaceuticals Incorporated
- RECRUITINGNCT07363304Impact of Elexacaftor-Tezacaftor-Ivacaftor Treatment on Metabolic, Epigenetic and Fecal Microbiota Profiles in People With Cystic Fibrosis.Meyer Children's Hospital IRCCS